You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 81 - 90 of 4368 results
  1. Preclinical Evaluation of a Novel Immunomodulatory Vaccine for Preventing and Treating HSV Infections

    SBC: Rational Vaccines, Inc.            Topic: NIAID

    PROJECT SUMMARY: Herpes Simplex Virus (HSV) infections are common, infecting more than half of the world’s population. While most cases of genital herpes are caused by HSV type 2 (HSV-2), it is estimated that more than 150 million people aged 15-49 have genital HSV type 1 (HSV-1) infections. Although several vaccines have been evaluated for preventing/treating HSV infections, none have received ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  2. Developing a virtual reality guided acupuncture imagery treatment for Chronic low back pain

    SBC: MASSACHUSETTS NEURO TECHNOLOGY, INC.            Topic: NCCIH

    Project Summary Low back pain (LBP) is one of the most common reasons for physician visits in the USA. A substantial number of chronic LBP (cLBP) patients do not adequately respond to current treatment options. Thus, the development of new treatments for cLBP is urgently needed. The use of imagery to treat illness, including chronic pain, is one of the oldest medical practices. Although still unde ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  3. Fast Field Screening of PFAS in Non-Portable Waters..

    SBC: 2witech Solutions LLC            Topic: NIEHS

    Project Summary/Abstract: 2Witech Solutions LLC proposes a Phase I Small Business Innovation Research project to develop a portable electrochemical sensing device for quick field screening of trace PFAS in non-potable waters (groundwater, surface water, and wastewater) by combining its recent achievement in molecular- imprinting technology and electrochemical sensor development. The overall object ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  4. Clinical Studies for Improving Survival Rates for Oral Cancer Patients in Low Resource Settings

    SBC: PRIVO TECHNOLOGIES, LLC            Topic: 102

    Project Summary Oral cancer (OC) is an underserved disease, which is often overlooked by the medical community. Yet it is the 6th mostcommon and deadliest cancer in the world. According to the Oral Cancer Foundation, over 90% of all oral cancers are oralsquamous cell carcinoma (OSCC) - a common subset of head and neck cancers. OC claims the life of one American everyhour of each day. Additionally, ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  5. Point-of-care lateral flow immunoassay for diagnosis of pertussis

    SBC: DXDISCOVERY INC            Topic: NIAID

    Pertussis (Whooping cough) is a highly contagious, airborne disease that is rapidly re-emerging as a serious public health threat in the United States. Despite high vaccine coverage, annual reported cases in the U.S. have been increasing recently, with an average of 25,000 per year from 2010-2019. This is a level unseen since the early 1960s. Diagnosis of pertussis is challenging because its early ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  6. Diagnostic tool for assessment and tracking of microbial load in bloodstream infections

    SBC: HELIXBIND, INC.            Topic: NIAID

    PROJECT SUMMARY Leading to over 270,000 deaths in the US annually, septicemia is the systemic inflammatory response to a bloodstream infection (BSI). Early diagnosis and treatment of BSIs have demonstrated improved patient outcomes and reduced hospitalization time. However, currently accepted diagnostic approaches require a blood culturing step, which is not only slow, but also demonstrates reduce ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  7. A state-of-the-art web platform for collaborative, longitudinal genome diagnostics

    SBC: FRAMESHIFT LABS INC            Topic: 172

    Summary/Abstract Undiagnosed diseases clinics and newborn intensive care unit rapid genome sequencing programs have emerged as the primary settings for diagnosing patients with complex phenotypes. Subspecialty clinics, pharmaceutical companies, and direct-to-consumer genetic testing companies are increasingly adopting these technologies for diagnosing patients, or studying disease with the goal of ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  8. Development of Cell Culture Inserts and 3D In Vitro Tissue Models Utilizing Novel Electrospun Scaffolds

    SBC: BIOSURFACES INC            Topic: R

    Tissue culture inserts that utilize film-based microporous membrane scaffolds are key components of in vitro tissue models that are used as alternatives to animal testing. However, insert scaffold technology has not significantly advanced in nearly 30 years. Currently available film-based insert scaffolds are only 2-dimensional (2D), and are excessively rigid compared to natural extracellular matr ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  9. First-in-class TREM-1 inhibitors for neovascular retinal diseases

    SBC: SIGNABLOK, INC.            Topic: 100

    Project Summary/Abstract Retinal neovascularization (RNV) is a major cause of vision loss in retinopathy of prematurity (ROP), diabetic retinopathy (DR) and retinal vein occlusion. In the US, about 16,000 of premature infants are affected by ROP annually and about 4.1 million adults years have DR. Complications of conventional treatments suggest an unmet need for new therapies. The long-term objec ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  10. Point of Care maternal milk concentration device to optimize neonatal growth with targeted nutrition support

    SBC: MOTHER'S MILK IS BEST, INC.            Topic: NICHD

    Project Summary This is an innovation that embodies the NIH mission of improving healthcare outcomes by providing preterm infants the valuable nutrients only found in mother’s milk increasing their chance of survival and improved overall health. The goal of this research is to tailor the technology to the specific needs of the NICU and prove superior performance in decreasing feeding intolerance ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government